MTSR Stock Price | Metsera, Inc. Common Stock P/E, Revenue, EPS, & Forecasts

Metsera, Inc. Common Stock • MTSR

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Metsera, Inc. Common Stock

Ticker

MTSR

Trading on

NASDAQ

ISIN

US59267L1070

Industry

Biotechnology

Sector

Healthcare

CEO

Christopher Whitten Bernard

Headquarters

3 World Trade Center, New York, NY, United States, 10007

Employees

104

Website

https://metsera.com

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York.

Metrics

BasicAdvanced

Market cap

$4.12B

P/E ratio

EPS

-$2.53

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-178M

Ex dividend date

Price & volume

Market cap

$4.12B

Average daily volume

2.8M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

8.3

Earnings

EPS

-$2.53

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-178M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

52-week High

$82.79

52-week Low

$12.30

50-day moving average

$30.58

200-day moving average

$27.45

Short ratio

9.43

Short %

70.44%

Management effectiveness

ROE (TTM)

0.00%

ROA (TTM)

0.00%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

105M

Float

64.5M

Insiders %

13.07%

Institutions %

78.08%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 4 analysts.

Average price target

$55.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$3.52

-$0.80

-340.00%

Q4 • 24Missed

-$1.03

-$1.04

0.96%

Q1 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-76.6M

-∞%

Q1 • 25

$0M

$-68.7M

-∞%

Q2 • 25

NaN%

-10.28%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$691M

$185M

26.83%

Q1 • 25

$640M

$190M

29.77%

Q2 • 25

-7.39%

2.76%

10.96%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-54.3M

$-0M

$289M

$-54.3M

Q1 • 25

$-59M

$-0.2M

$-1.5M

$-59.2M

Q2 • 25

8.51%

2,628.57%

-100.52%

8.84%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Metsera, Inc. Common Stock share?

Metsera, Inc. Common Stock shares are currently traded for undefined per share.

How many shares does Metsera, Inc. Common Stock have?

Metsera, Inc. Common Stock currently has 105M shares.

Does Metsera, Inc. Common Stock pay dividends?

No, Metsera, Inc. Common Stock doesn't pay dividends.

What is Metsera, Inc. Common Stock 52 week high?

Metsera, Inc. Common Stock 52 week high is $82.79.

What is Metsera, Inc. Common Stock 52 week low?

Metsera, Inc. Common Stock 52 week low is $12.30.

What is the 200-day moving average of Metsera, Inc. Common Stock?

Metsera, Inc. Common Stock 200-day moving average is $27.45.

Who is Metsera, Inc. Common Stock CEO?

The CEO of Metsera, Inc. Common Stock is Christopher Whitten Bernard.

How many employees Metsera, Inc. Common Stock has?

Metsera, Inc. Common Stock has 104 employees.

What is the market cap of Metsera, Inc. Common Stock?

The market cap of Metsera, Inc. Common Stock is $4.12B.

What is the P/E of Metsera, Inc. Common Stock?

The current P/E of Metsera, Inc. Common Stock is null.

What is the EPS of Metsera, Inc. Common Stock?

The EPS of Metsera, Inc. Common Stock is -$2.53.

What is the PEG Ratio of Metsera, Inc. Common Stock?

The PEG Ratio of Metsera, Inc. Common Stock is null.

What do analysts say about Metsera, Inc. Common Stock?

According to the analysts Metsera, Inc. Common Stock is considered a buy.